FHTX (Foghorn Therapeutics Inc.) Stock Market Reviews

crown

search

Read and share opinions on FHTX (Foghorn Therapeutics Inc.) stock. Join MyTopStock.com to discover reviews, insights, and discussions from investors about this company's performance in the stock marke

FHTX

Foghorn Therapeutics Inc.

clarify Biotechnology

bookmark Healthcare

public United States

Sell Neutral Buy

Latest News

Foghorn Therapeutics (FHTX): Forecast 28.8% Revenue Growth Challenges Ongoing Loss Narrative
Nov 6, 2025
Foghorn Therapeutics Inc. (FHTX) Reports Q3 Loss, Beats Revenue Estimates
Nov 5, 2025
Foghorn Therapeutics to Participate in Three Upcoming Investor Conferences
Nov 3, 2025
Foghorn Therapeutics Announces Significant Progress for Selective ARID1B Degrader at the 8th Annual TPD and Induced Proximity Summit
Oct 16, 2025
Wall Street Analysts Predict a 130.63% Upside in Foghorn Therapeutics (FHTX): Here's What You Should Know
Sep 1, 2025
Is Arcutis Biotherapeutics (ARQT) Stock Outpacing Its Medical Peers This Year?
Aug 27, 2025
Foghorn Therapeutics (FHTX) Upgraded to Buy: Here's Why
Aug 25, 2025
Here's Why Foghorn Therapeutics (FHTX) Looks Ripe for Bottom Fishing
Aug 8, 2025
Foghorn Therapeutics Inc. (FHTX) Reports Q2 Loss, Lags Revenue Estimates
Aug 5, 2025
Is Foghorn Therapeutics (NASDAQ:FHTX) In A Good Position To Invest In Growth?
Aug 5, 2025
Foghorn Therapeutics to Participate in Four Upcoming Investor Conferences
May 22, 2025
Foghorn Therapeutics Inc. (FHTX) Reports Q1 Loss, Misses Revenue Estimates
May 14, 2025
Foghorn Therapeutics to Participate in the Citizens Life Sciences Conference
May 5, 2025

Reviews